Cargando…
Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
BACKGROUND: Heart failure (HF) with preserved ejection fraction (HFpEF) is increasingly recognized as an important clinical entity. Preclinical studies have shown differences in the pathophysiology between HFpEF and HF with reduced ejection fraction (HFrEF). Therefore, we hypothesized that a systema...
Autores principales: | Zordoky, Beshay N., Sung, Miranda M., Ezekowitz, Justin, Mandal, Rupasri, Han, Beomsoo, Bjorndahl, Trent C., Bouatra, Souhaila, Anderson, Todd, Oudit, Gavin Y., Wishart, David S., Dyck, Jason R. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444296/ https://www.ncbi.nlm.nih.gov/pubmed/26010610 http://dx.doi.org/10.1371/journal.pone.0124844 |
Ejemplares similares
-
The Human Urine Metabolome
por: Bouatra, Souhaila, et al.
Publicado: (2013) -
A prospective evaluation of the established criteria for heart failure with preserved ejection fraction using the Alberta HEART cohort
por: Ezekowitz, Justin A., et al.
Publicado: (2017) -
HMDB 3.0—The Human Metabolome Database in 2013
por: Wishart, David S., et al.
Publicado: (2013) -
Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020) -
Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in Pathophysiology
por: Putko, Brendan N., et al.
Publicado: (2014)